Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Ottawa

$26,000.00

Structure/function studies of adenovirus capsid protein IX

EF 2012-13

Résumé
Viruses are very good at delivering their DNA into cells, and this observation has been exploited to develop highly-attenuated viruses (no longer cause disease) that can deliver any gene-of-interest to cells in the laboratory for experimental study. In this application, we will continue our research program dedicated to improving our understanding of basic aspects of Ad biology that contributes to its function as an efficient gene delivery system. Our current work is focused on a viral protein, called protein IX. This protein is directly involved in helping the virus gain entry into the cell, and also appears to have a second function in reducing the effectiveness of the cell's natural defenses against infection. We will determine the mechanism of how the virus and protein are capable of doing this, which will provide novel insight into anti-viral proteins within the cell and how viruses interact with them. Recently, we showed that we could modify protein IX in order to target virus infection to specific cell types, such as cancer cells. However, although delivery was effective, these viruses now have a reduced ability to carry normal amounts of DNA, for reasons which are unclear. We will determine the nature of this deficiency and explore methods to correct it. Taken together, our current work on pIX will provide insight into virus structure, infection, and replication, and will also elucidate cellular proteins that act as anti-viral defense factors, further highlighting the ongoing battle between host and pathogen. In addition, we will refine our ability to produce Ad-based gene delivery systems that can be targeted to specific cell types and tissues, which ultimately will benefit many researchers utilizing Ad as a gene delivery tool.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
238824-2012
Name nom
Parks, Robin
Department département
Biochemistry, Microbiology and Immunology
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
26000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Virology
Research subject fr
Virologie
Partie
1
Nb partie
1
Application title
Structure/function studies of adenovirus capsid protein IX
Keyword
NSERC
Application summary
Viruses are very good at delivering their DNA into cells, and this observation has been exploited to develop highly-attenuated viruses (no longer cause disease) that can deliver any gene-of-interest to cells in the laboratory for experimental study. In this application, we will continue our research program dedicated to improving our understanding of basic aspects of Ad biology that contributes to its function as an efficient gene delivery system. Our current work is focused on a viral protein, called protein IX. This protein is directly involved in helping the virus gain entry into the cell, and also appears to have a second function in reducing the effectiveness of the cell's natural defenses against infection. We will determine the mechanism of how the virus and protein are capable of doing this, which will provide novel insight into anti-viral proteins within the cell and how viruses interact with them. Recently, we showed that we could modify protein IX in order to target virus infection to specific cell types, such as cancer cells. However, although delivery was effective, these viruses now have a reduced ability to carry normal amounts of DNA, for reasons which are unclear. We will determine the nature of this deficiency and explore methods to correct it. Taken together, our current work on pIX will provide insight into virus structure, infection, and replication, and will also elucidate cellular proteins that act as anti-viral defense factors, further highlighting the ongoing battle between host and pathogen. In addition, we will refine our ability to produce Ad-based gene delivery systems that can be targeted to specific cell types and tissues, which ultimately will benefit many researchers utilizing Ad as a gene delivery tool.